Search

Your search keyword '"ANAKINRA"' showing total 5,204 results

Search Constraints

Start Over You searched for: Descriptor "ANAKINRA" Remove constraint Descriptor: "ANAKINRA"
5,204 results on '"ANAKINRA"'

Search Results

1. Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis.

2. IL‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results.

3. Recurrent pericarditis in older adults: Clinical and laboratory features and outcome.

4. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature.

5. The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever.

6. Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene.

7. Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy.

8. Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-- the FertIL trial.

9. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy.

10. Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis.

11. Physiologically Based Pharmacokinetic Modelling in Critically Ill Children Receiving Anakinra While on Extracorporeal Life Support.

12. Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva.

13. Single Center-Based Real-World Experience on Anti-IL 1 Biological Response Modifiers: A Case Series and Literature Review.

14. Retrospective evaluation of obstetric processes in patients with Familial Mediterranean Fever's disease: The three years experience of a tertiary rheumatology clinic

15. Safety and Efficacy Evaluation of PerkinRA in Comparison with Kineret in Systemic Juvenile Idiopathic Arthritis Patients

16. Early Infantile Hemophagocytic Lymphohistiocytosis Masquerading as Late-onset Sepsis: A Case Report with Review of the Literature

17. Effectiveness of early Anakinra on cardiac function in children with multisystem inflammatory syndrome of COVID-19: a systematic review

18. Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy

19. Effectiveness of early Anakinra on cardiac function in children with multisystem inflammatory syndrome of COVID-19: a systematic review.

20. Trends in management of patients with new‐onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis.

21. Schnitzler's Syndrome—Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.

22. Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy.

23. The sharp edge of immunosuppressive treatments: infections.

24. Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management.

25. Analysing of The Effects of an Interleukin - 1 Receptor Antagonist and a RNA Polymerase Inhibitor on Neurodegeneration in the Hippocampal Cell Line.

26. Hämophagozytische Lymphohistiozytose und Makrophagenaktivierungssyndrom: Eine multidisziplinäre Herausforderung.

28. Efficacy and safety of anakinra in radiation-induced acute pericarditis: a case report

29. Investigating the impact of Tocilizumab, Sarilumab, and Anakinra on clinical outcomes in COVID-19: A systematic review and meta-analysis

30. Pericarditis as an interdisciplinary problem. In anticipation of the update of the European Society of Cardiology guidelines

31. Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial

32. Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients.

33. IL-1 Family Blockade in Cytokine Storm Syndromes

34. Systemic Lupus Erythematosus and Cytokine Storm

35. Anti-inflammatory Therapy and Pleiotropic Effects of Drugs in the Treatment of Cardiovascular Diseases Due to Environmental Factors

36. Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial

37. Postpartum fevers, a rare presentation of secondary hemophagocytic lymphohistiocytosis.

40. Intravenous high-dose anakinra drops venous thrombosis and acute coronary syndrome in severe and critical COVID-19 patients: a propensity score matched study

41. Cardiovascular involvement in children with COVID-19 temporally related multisystem inflammatory syndrome (MIS-C): can cardiac magnetic resonance arrive to the heart of the problem?

42. CINCA/NOMID is a rare autoinflammatory syndrome in rheumatological practice. Experience of diagnosis, management and therapy with interleukin-1 inhibitors

43. Case report: Rapid resolution of grade IV ICANS after first line intrathecal chemotherapy with methotrexate, cytarabine and dexamethasone.

44. Cardiovascular involvement in children with COVID-19 temporally related multisystem inflammatory syndrome (MIS-C): can cardiac magnetic resonance arrive to the heart of the problem?

45. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.

46. Second‐line immunotherapy in new onset refractory status epilepticus.

47. The clinical role of anakinra in the armamentarium against familial Mediterranean fever.

48. Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis.

49. Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID‐19 Under the Emergency Use Authorization.

50. Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.

Catalog

Books, media, physical & digital resources